Company Filing History:
Years Active: 2013
Title: Prabhu Daivasigamani: Innovator in Histone Deacetylase Inhibitors
Introduction
Prabhu Daivasigamani is a notable inventor based in Tirupati, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that target histone deacetylase (HDAC) enzymes. His work is crucial in the treatment of various medical conditions, including cancer and psoriasis.
Latest Patents
Prabhu Daivasigamani holds a patent for histone deacetylase inhibitors, which includes novel compounds of the general formula (I). These compounds exhibit HDAC inhibiting enzymatic activity and encompass their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, intermediates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites, and prodrugs. The invention also outlines a method for treating cancer, psoriasis, proliferative conditions, and other conditions mediated by HDAC in mammals through the administration of an effective amount of the novel compound.
Career Highlights
Prabhu is associated with Orchid Chemicals & Pharmaceuticals Limited, where he applies his expertise in pharmaceutical innovation. His work has contributed to the advancement of therapeutic options available for patients suffering from serious health conditions.
Collaborations
Prabhu has collaborated with notable colleagues, including Sridharan Rajagopal and Virendra Kachhadia, to further enhance the research and development of pharmaceutical products.
Conclusion
Prabhu Daivasigamani's innovative work in the field of histone deacetylase inhibitors showcases his commitment to advancing medical science. His contributions are vital for developing effective treatments for various diseases, highlighting the importance of innovation in healthcare.